PetIQ, Inc. (PETQ) Misses Q4 EPS by 51c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2021 Financial Results
March 1, 2022 4:05 PM ESTReports Fourth Quarter Net Sales of $196.6 Million and Full Year Net Sales of $932.5 Million
Company Provides First Quarter 2022 and Full Year 2022 Outlook
EAGLE, Idaho, March 01, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the fourth quarter and full year ended December 31, 2021.
Cord Christensen, PetIQs Chairman & CEO commented, We are very pleased with our strong finish to 2021. Our record fourth quarter was better than we expected driven by... More
